BABAR, Z.; AREESHA BABAR. FDA’s New Approval: Kisunla (Donanemab-Azbt) - A Major Breakthrough in Alzheimer’s Care. Journal of the Pakistan Medical Association, [S. l.], v. 75, n. 07, p. 1156–1156, 2025. DOI: 10.47391/JPMA.21951. Disponível em: https://jpma.org.pk/index.php/public_html/article/view/21951. Acesso em: 21 apr. 2026.